Jinhua Zhang
CEO
IASO BioTherapeutics（驯鹿生物）
IASO Biotherapeutics develops cell therapies targeting specific cancer types by utilizing engineered immune cells to enhance the body’s natural ability to fight tumors. The company aims to improve patient outcomes in oncology by providing more effective treatment options for resistant cancer forms.
- Biotechnology
Updated 23 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- IASO Biotherapeutics develops cell therapies targeting specific cancer types by utilizing engineered immune cells to enhance the body’s natural ability to fight tumors. The company aims to improve patient outcomes in oncology by providing more effective treatment options for resistant cancer forms.